O. v. Deimling
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism
Papers in
- Pharmacology 20
- Cholinesterase and Neurodegenerative Diseases 19
- Pharmacogenetics and Drug Metabolism 7
-
- Amino Acid Enzymes and Metabolism 7
- Co-authors
- Adam RonaiH NolteniusEberhard HeymannAlfred BöckingFranz DuspivaRolf MentleinSukumar MeddaMariette Robbi
- Journals
- Histochemistry and Cell Biology (34 papers)Biochemical Genetics (10 papers)European Journal of Biochemistry (3 papers)Mammalian Genome (2 papers)Genomics (2 papers)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
O. v. Deimling
97 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 97
- Pharmacology 315
- Biochemistry 101
- Pharmacology 109
- Molecular Biology 774
- Computational Theory and Mathematics 144
Countries citing papers authored by O. v. Deimling
This map shows the geographic impact of O. v. Deimling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. v. Deimling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. v. Deimling more than expected).
Fields of papers citing papers by O. v. Deimling
This network shows the impact of papers produced by O. v. Deimling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. v. Deimling. The network helps show where O. v. Deimling may publish in the future.
Co-authors
The 25 scholars most cited alongside O. v. Deimling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 9 | |
| 2 | 1993 | 7 | |
| 3 | 1992 | 4 | |
| 4 | 1992 | 4 | |
| 5 | 1991 | 55 | |
| 6 | 1990 | 3 | |
| 7 | 1990 | 1 | |
| 8 | 1989 | 24 | |
| 9 | 1988 | 11 | |
| 10 | 1988 | 4 | |
| 11 | 1979 | 25 | |
| 12 | 1976 | 11 | |
| 13 | 1972 | 6 | |
| 14 | 1970 | 23 | |
| 15 | 1969 | 4 | |
| 16 | 1968 | 1 | |
| 17 | 1967 | 13 | |
| 18 | 1967 | 10 | |
| 19 | 1965 | 27 | |
| 20 | 1960 | 57 |
About O. v. Deimling
O. v. Deimling is a scholar working on Pharmacology, Biochemistry, Physical and Theoretical Chemistry, Pharmacology and Molecular Biology, having authored 98 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (19 papers), Enzyme function and inhibition (13 papers), thermodynamics and calorimetric analyses (9 papers), Computational Drug Discovery Methods (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Protein Hydrolysis and Bioactive Peptides (7 papers), Amino Acid Enzymes and Metabolism (7 papers) and Mass Spectrometry Techniques and Applications (6 papers). The work is most often cited by research in Pharmacology (315 citations), Biochemistry (101 citations), Pharmacology (109 citations), Molecular Biology (774 citations) and Computational Theory and Mathematics (144 citations). O. v. Deimling has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Adam Ronai, H Noltenius, Eberhard Heymann, Alfred Böcking, Franz Duspiva, Rolf Mentlein, Sukumar Medda, Mariette Robbi, Richard T. Swank and Howard Nash. Their work appears in journals such as Histochemistry and Cell Biology, Biochemical Genetics, European Journal of Biochemistry, Mammalian Genome and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.